作为抗癌剂的皮皮里丁-二皮里丁混合体的设计,合成和体内研究
Swathi Rejinthala1, Srinivas Endoori2, Vishnu Thumma3
1Department of Engineering Chemistry, Koneru Lakshmaiah Education Foundation, Aziznagar, Hyderabad, 500075, Telangana, India.
Chemistry & biodiversity
|February 17, 2024
概括
新型piperidine-dihydropyridine杂交物对肺癌和乳腺癌细胞系表现出强大的抗癌活性. 确定了用于进一步药物开发的有希望的化合物,其特定的替代物增强了疗效.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 开发新的抗癌药物对于对抗耐药性癌症至关重要.
- 皮皮里丁和二皮里丁支架因其多样化的生物活动而闻名.
- 混合分子提供了结合有益特性和增强治疗潜力的机会.
研究的目的:
- 设计,合成和表征新的皮佩里丁-二二二杂交化合物.
- 评估这些化合物对人类乳腺癌 (MCF-7) 和肺癌 (A-549) 细胞系的体外抗癌活性.
- 通过分子对接研究来调查潜在的作用机制.
主要方法:
- 合成皮佩里丁-二皮里丁杂交物.
- 使用NMR (1H, 13C),质谱和元素分析进行了表征.
- 针对MCF-7和A-549细胞系的体外细胞毒性测定 (IC50测定).
- 对抗表皮生长因子受体 (EGFR) 的分子对接.
主要成果:
- 几种合成的化合物表现出显著的抗癌活性.
- IC50值在15.94微米至59.12微米之间.
- 一种3替代化合物显示出强烈的活性 (IC50:15.94微米对抗A-549,22.12微米对抗MCF-7).
- 一种含有环丁环的化合物也表现出强烈的活性 (IC50:16.56微米对抗A-549,24.68微米对抗MCF-7).
- 分子对接表明与EGFR的良好相互作用.
结论:
- 这种新型的皮佩里丁-二皮里丁杂交物具有有前途的抗癌特性.
- 特定的结构修改,如3 - 替代和循环丁环的加入,增强了活性.
- 这些化合物代表了开发针对EGFR的新抗癌疗法的潜在线索.
相关概念视频
Structure-Activity Relationships and Drug Design
720
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
720
Basicity of Heterocyclic Aromatic Amines
6.0K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.0K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K


